Global and China Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2020-2026

Global and China Alpha- Antitrypsin Deficiency Treatment Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 CT-2009
1.2.3 POL-6014
1.2.4 ARO-AAT
1.2.5 ALNAAT-02
1.2.6 Others
1.3 Market by Application
1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2020 VS 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Perspective (2015-2026)
2.2 Global Alpha- Antitrypsin Deficiency Treatment Growth Trends by Regions
2.2.1 Alpha- Antitrypsin Deficiency Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alpha- Antitrypsin Deficiency Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Market Size
3.1.1 Global Top Alpha- Antitrypsin Deficiency Treatment Players by Revenue (2015-2020)
3.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alpha- Antitrypsin Deficiency Treatment Revenue
3.4 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio
3.4.1 Global Alpha- Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha- Antitrypsin Deficiency Treatment Revenue in 2019
3.5 Key Players Alpha- Antitrypsin Deficiency Treatment Area Served
3.6 Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Alpha- Antitrypsin Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Type (2015-2026)
4.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Type (2015-2020)
4.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Type (2021-2026)
5 Alpha- Antitrypsin Deficiency Treatment Breakdown Data by Application (2015-2026)
5.1 Global Alpha- Antitrypsin Deficiency Treatment Historic Market Size by Application (2015-2020)
5.2 Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
6.2 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
6.3 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
6.4 North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
7.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
7.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
7.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
8.2 China Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
8.3 China Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
8.4 China Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
9.2 Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
9.3 Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
9.4 Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size (2015-2026)
10.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Adverum Biotechnologies, Inc.
11.1.1 Adverum Biotechnologies, Inc. Company Details
11.1.2 Adverum Biotechnologies, Inc. Business Overview
11.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.1.4 Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020))
11.1.5 Adverum Biotechnologies, Inc. Recent Development
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Details
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.3 Applied Genetic Technologies Corporation
11.3.1 Applied Genetic Technologies Corporation Company Details
11.3.2 Applied Genetic Technologies Corporation Business Overview
11.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
11.3.4 Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.3.5 Applied Genetic Technologies Corporation Recent Development
11.4 Arrowhead Pharmaceuticals, Inc.
11.4.1 Arrowhead Pharmaceuticals, Inc. Company Details
11.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
11.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.4.4 Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.4.5 Arrowhead Pharmaceuticals, Inc. Recent Development
11.5 Carolus Therapeutics, Inc.
11.5.1 Carolus Therapeutics, Inc. Company Details
11.5.2 Carolus Therapeutics, Inc. Business Overview
11.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.5.4 Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.5.5 Carolus Therapeutics, Inc. Recent Development
11.6 Cevec Pharmaceuticals GmbH
11.6.1 Cevec Pharmaceuticals GmbH Company Details
11.6.2 Cevec Pharmaceuticals GmbH Business Overview
11.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Introduction
11.6.4 Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.6.5 Cevec Pharmaceuticals GmbH Recent Development
11.7 Dicerna Pharmaceuticals, Inc.
11.7.1 Dicerna Pharmaceuticals, Inc. Company Details
11.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.7.4 Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.7.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.8 Digna Biotech, S.L.
11.8.1 Digna Biotech, S.L. Company Details
11.8.2 Digna Biotech, S.L. Business Overview
11.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Introduction
11.8.4 Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.8.5 Digna Biotech, S.L. Recent Development
11.9 Editas Medicine, Inc.
11.9.1 Editas Medicine, Inc. Company Details
11.9.2 Editas Medicine, Inc. Business Overview
11.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
11.9.4 Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.9.5 Editas Medicine, Inc. Recent Development
11.10 Grifols, S.A.
11.10.1 Grifols, S.A. Company Details
11.10.2 Grifols, S.A. Business Overview
11.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Introduction
11.10.4 Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
11.10.5 Grifols, S.A. Recent Development
11.11 Inhibrx
10.11.1 Inhibrx Company Details
10.11.2 Inhibrx Business Overview
10.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Introduction
10.11.4 Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.11.5 Inhibrx Recent Development
11.12 Intellia Therapeutics, Inc.
10.12.1 Intellia Therapeutics, Inc. Company Details
10.12.2 Intellia Therapeutics, Inc. Business Overview
10.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
10.12.4 Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.12.5 Intellia Therapeutics, Inc. Recent Development
11.13 International Stem Cell Corporation
10.13.1 International Stem Cell Corporation Company Details
10.13.2 International Stem Cell Corporation Business Overview
10.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Introduction
10.13.4 International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.13.5 International Stem Cell Corporation Recent Development
11.14 Ionis Pharmaceuticals, Inc.
10.14.1 Ionis Pharmaceuticals, Inc. Company Details
10.14.2 Ionis Pharmaceuticals, Inc. Business Overview
10.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
10.14.4 Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.14.5 Ionis Pharmaceuticals, Inc. Recent Development
11.15 Kamada Ltd.
10.15.1 Kamada Ltd. Company Details
10.15.2 Kamada Ltd. Business Overview
10.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
10.15.4 Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.15.5 Kamada Ltd. Recent Development
11.16 Polyphor Ltd.
10.16.1 Polyphor Ltd. Company Details
10.16.2 Polyphor Ltd. Business Overview
10.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Introduction
10.16.4 Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.16.5 Polyphor Ltd. Recent Development
11.17 ProMetic Life Sciences Inc.
10.17.1 ProMetic Life Sciences Inc. Company Details
10.17.2 ProMetic Life Sciences Inc. Business Overview
10.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
10.17.4 ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.17.5 ProMetic Life Sciences Inc. Recent Development
11.18 rEVO Biologics, Inc.
10.18.1 rEVO Biologics, Inc. Company Details
10.18.2 rEVO Biologics, Inc. Business Overview
10.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
10.18.4 rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.18.5 rEVO Biologics, Inc. Recent Development
11.19 Sangamo BioSciences, Inc.
10.19.1 Sangamo BioSciences, Inc. Company Details
10.19.2 Sangamo BioSciences, Inc. Business Overview
10.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Introduction
10.19.4 Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
10.19.5 Sangamo BioSciences, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of CT-2009
Table 4. Key Players of POL-6014
Table 5. Key Players of ARO-AAT
Table 6. Key Players of ALNAAT-02
Table 7. Key Players of Others
Table 8. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2015-2020)
Table 12. Global Alpha- Antitrypsin Deficiency Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2021-2026)
Table 14. Alpha- Antitrypsin Deficiency Treatment Market Market Trends
Table 15. Alpha- Antitrypsin Deficiency Treatment Market Drivers
Table 16. Alpha- Antitrypsin Deficiency Treatment Market Challenges
Table 17. Alpha- Antitrypsin Deficiency Treatment Market Restraints
Table 18. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Players (2015-2020)
Table 20. Global Top Alpha- Antitrypsin Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2019)
Table 21. Global Alpha- Antitrypsin Deficiency Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alpha- Antitrypsin Deficiency Treatment Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Alpha- Antitrypsin Deficiency Treatment Market Size Share by Type (2015-2020)
Table 27. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Type (2021-2026)
Table 28. Global Alpha- Antitrypsin Deficiency Treatment Market Size Share by Application (2015-2020)
Table 29. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Alpha- Antitrypsin Deficiency Treatment Market Size Share by Application (2021-2026)
Table 31. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2015-2020)
Table 33. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2015-2020)
Table 35. North America Alpha- Antitrypsin Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2015-2020)
Table 37. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2015-2020)
Table 39. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2015-2020)
Table 41. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2015-2020)
Table 43. China Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 44. China Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2015-2020)
Table 45. China Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 46. China Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2015-2020)
Table 47. China Alpha- Antitrypsin Deficiency Treatment Market Size by Region (US$ Million) (2015-2020)
Table 48. China Alpha- Antitrypsin Deficiency Treatment Market Share by Region (2015-2020)
Table 49. Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2015-2020)
Table 51. Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2015-2020)
Table 53. Japan Alpha- Antitrypsin Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2015-2020)
Table 55. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2015-2020)
Table 57. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Share by Country (2015-2020)
Table 61. Adverum Biotechnologies, Inc. Company Details
Table 62. Adverum Biotechnologies, Inc. Business Overview
Table 63. Adverum Biotechnologies, Inc. Product
Table 64. Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 65. Adverum Biotechnologies, Inc. Recent Development
Table 66. Alnylam Pharmaceuticals, Inc. Company Details
Table 67. Alnylam Pharmaceuticals, Inc. Business Overview
Table 68. Alnylam Pharmaceuticals, Inc. Product
Table 69. Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 70. Alnylam Pharmaceuticals, Inc. Recent Development
Table 71. Applied Genetic Technologies Corporation Company Details
Table 72. Applied Genetic Technologies Corporation Business Overview
Table 73. Applied Genetic Technologies Corporation Product
Table 74. Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 75. Applied Genetic Technologies Corporation Recent Development
Table 76. Arrowhead Pharmaceuticals, Inc. Company Details
Table 77. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 78. Arrowhead Pharmaceuticals, Inc. Product
Table 79. Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 80. Arrowhead Pharmaceuticals, Inc. Recent Development
Table 81. Carolus Therapeutics, Inc. Company Details
Table 82. Carolus Therapeutics, Inc. Business Overview
Table 83. Carolus Therapeutics, Inc. Product
Table 84. Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 85. Carolus Therapeutics, Inc. Recent Development
Table 86. Cevec Pharmaceuticals GmbH Company Details
Table 87. Cevec Pharmaceuticals GmbH Business Overview
Table 88. Cevec Pharmaceuticals GmbH Product
Table 89. Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 90. Cevec Pharmaceuticals GmbH Recent Development
Table 91. Dicerna Pharmaceuticals, Inc. Company Details
Table 92. Dicerna Pharmaceuticals, Inc. Business Overview
Table 93. Dicerna Pharmaceuticals, Inc. Product
Table 94. Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 95. Dicerna Pharmaceuticals, Inc. Recent Development
Table 96. Digna Biotech, S.L. Business Overview
Table 97. Digna Biotech, S.L. Product
Table 98. Digna Biotech, S.L. Company Details
Table 99. Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 100. Digna Biotech, S.L. Recent Development
Table 101. Editas Medicine, Inc. Company Details
Table 102. Editas Medicine, Inc. Business Overview
Table 103. Editas Medicine, Inc. Product
Table 104. Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 105. Editas Medicine, Inc. Recent Development
Table 106. Grifols, S.A. Company Details
Table 107. Grifols, S.A. Business Overview
Table 108. Grifols, S.A. Product
Table 109. Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 110. Grifols, S.A. Recent Development
Table 111. Inhibrx Company Details
Table 112. Inhibrx Business Overview
Table 113. Inhibrx Product
Table 114. Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 115. Inhibrx Recent Development
Table 116. Intellia Therapeutics, Inc. Company Details
Table 117. Intellia Therapeutics, Inc. Business Overview
Table 118. Intellia Therapeutics, Inc. Product
Table 119. Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 120. Intellia Therapeutics, Inc. Recent Development
Table 121. International Stem Cell Corporation Company Details
Table 122. International Stem Cell Corporation Business Overview
Table 123. International Stem Cell Corporation Product
Table 124. International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 125. International Stem Cell Corporation Recent Development
Table 126. Ionis Pharmaceuticals, Inc. Company Details
Table 127. Ionis Pharmaceuticals, Inc. Business Overview
Table 128. Ionis Pharmaceuticals, Inc. Product
Table 129. Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 130. Ionis Pharmaceuticals, Inc. Recent Development
Table 131. Kamada Ltd. Company Details
Table 132. Kamada Ltd. Business Overview
Table 133. Kamada Ltd. Product
Table 134. Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 135. Kamada Ltd. Recent Development
Table 136. Polyphor Ltd. Company Details
Table 137. Polyphor Ltd. Business Overview
Table 138. Polyphor Ltd. Product
Table 139. Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 140. Polyphor Ltd. Recent Development
Table 141. ProMetic Life Sciences Inc. Company Details
Table 142. ProMetic Life Sciences Inc. Business Overview
Table 143. ProMetic Life Sciences Inc. Product
Table 144. ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 145. ProMetic Life Sciences Inc. Recent Development
Table 146. rEVO Biologics, Inc. Company Details
Table 147. rEVO Biologics, Inc. Business Overview
Table 148. rEVO Biologics, Inc. Product
Table 149. rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 150. rEVO Biologics, Inc. Recent Development
Table 151. Sangamo BioSciences, Inc. Company Details
Table 152. Sangamo BioSciences, Inc. Business Overview
Table 153. Sangamo BioSciences, Inc. Product
Table 154. Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020) (US$ Million)
Table 155. Sangamo BioSciences, Inc. Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Type: 2020 VS 2026
Figure 2. CT-2009 Features
Figure 3. POL-6014 Features
Figure 4. ARO-AAT Features
Figure 5. ALNAAT-02 Features
Figure 6. Others Features
Figure 7. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Alpha- Antitrypsin Deficiency Treatment Report Years Considered
Figure 12. Global Alpha- Antitrypsin Deficiency Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Regions (2021-2026)
Figure 15. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Players in 2019
Figure 16. Global Top Alpha- Antitrypsin Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Alpha- Antitrypsin Deficiency Treatment Revenue in 2019
Figure 18. North America Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Adverum Biotechnologies, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 46. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 47. Applied Genetic Technologies Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 48. Arrowhead Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 49. Carolus Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 50. Cevec Pharmaceuticals GmbH Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 51. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 52. Digna Biotech, S.L. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 53. Editas Medicine, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 54. Grifols, S.A. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 55. Inhibrx Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 56. Intellia Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 57. International Stem Cell Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 58. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 59. Kamada Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 60. Polyphor Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 61. ProMetic Life Sciences Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 62. rEVO Biologics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 63. Sangamo BioSciences, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs